QRG CAPITAL MANAGEMENT, INC.

Position in NVS — Novartis AG

CIK 1996454 BERWYN, PA

Position in NVS

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$25,776,992

+$2,735,571 QoQ

Shares Held

164,478

+9.0% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.23%

of 13F equity value

Holder Rank

#97

of 1,603 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

QRG CAPITAL MANAGEMENT, INC. holds $606,823,434 across 15 Drug Manufacturers - General names. NVS ranks #7 (4.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	146,305	$175,482,620
2	JNJ	Johnson & Johnson	440,815	$111,953,785
3	ABBV	AbbVie Inc.	301,006	$75,745,149
4	MRK	Merck & Co., Inc.	428,993	$55,125,600
5	AMGN	Amgen Inc	98,650	$35,723,138
6	GILD	Gilead Sciences, Inc.	227,523	$28,745,255
7	NVS	Novartis AG This page	164,478	$25,776,992
8	PFE	Pfizer Inc	902,308	$21,727,576

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$25,776,992	164,478	+9.0%	Shares	Sole	2026-07-14
2026-03-31	$23,041,421	150,844	+13.3%	Shares	Sole	2026-04-27
2025-12-31	$18,352,289	133,113	+6.0%	Shares	Sole	2026-02-02
2025-09-30	$16,098,480	125,534	-34.5%	Shares	Sole	2025-10-28
2025-06-30	$23,189,751	191,635	+3.1%	Shares	Sole	2025-07-21
2025-03-31	$20,720,564	185,868	-1.0%	Shares	Sole	2025-04-17
2024-12-31	$18,273,066	187,782	+5.9%	Shares	Sole	2025-02-05
2024-09-30	$20,388,790	177,263	-0.2%	Shares	Sole	2024-10-30
2024-06-30	$18,909,744	177,623	+5.4%	Shares	Sole	2024-07-12
2024-03-31	$16,302,100	168,532	+20.5%	Shares	Sole	2024-05-07
2023-12-31	$14,126,914	139,912	+8.0%	Shares	Sole	2024-02-07
2023-09-30	$13,195,046	129,541	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.